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Abstract: Plathymenia reticulata Benth has an anti-inflammatory effect and is capable of neutralizing the 
neuromuscular blockade induced by Bothrops jararacussu or Crotalus durissus terrificus venoms, probably 
by precipitating venom proteins (an effect caused by plant tannins). The present study aimed to evaluate 
the mutagenic activity of P. reticulata by using the Salmonella mutagenicity assay (Ames test) and the 
micronucleus test in CHO-K1 cells. P. reticulata extract concentrations of 2.84, 5.68, 11.37, and 19.90 mg/
plate were assayed by the Ames test using TA97a, TA98, TA100 and TA102 bacterial strains, with (+S9) and 
without (-S9) metabolic activation. Concentrations of 5, 1.6 and 0.5 μg/mL of P. reticulata extract were used 
for the micronucleus test. P. reticulata extract was mutagenic to TA98 (–S9) and showed signs of mutagenic 
activity in TA97a and TA102 (both –S9) strains. Micronucleus test CBPI values showed that the endogenous 
metabolic system increased the number of viable cells when compared to the non-activated samples and 
the micronucleus frequency increased when the cells were treated in the absence of S9. We concluded that 
P. reticulata extract may present direct mutagenic properties.
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INTRODUCTION
The Brazilian savanna, known as “cerrado”, 
is one of the most biologically diverse areas in 
Brazil. Plathymenia reticulata Benth, popularly 
known as “vinhático” (wine-like), belongs to the 
Leguminosae family, which is a source of high 
quality wood. It may also be useful in restoring 
deforested areas, mainly in the savanna region, 
making it an economically important tropical 
species (1).
P. reticulata has been used to treat 
inflammatory processes (throat) and diseases 
(diarrhea, dysenteries), in folk medicine (2). 
According to Pott and Pott (3), its bark is also 
used to make a medicinal bath for various 
illnesses (hemorrhage and insect bites). P. 
reticulata extract showed in vitro antimicrobial 
activity against Streptococcus mutans and 
Staphylococcus sp. (4). Leal et al. (5) reported the 
isolation and structural elucidation of two novel 
cassane diterpenes and the isolation of three 
previously reported compounds: plathyterpol, 
vinhaticyl acetate and methyl vinhaticoate (6, 
7). The recently described antiophidian property 
of P. reticulata hydroalcoholic extract obtained 
from its bark showed that tannins from this 
plant were able to precipitate proteins of both 
Crotalus and Bothrops venoms (8).
In the present study, the mutagenicity of 
P. reticulata bark was investigated by using 
Salmonella (Ames test) and CHO-K1 (Chinese 
hamster ovary) micronucleus assays, in order to 
observe its safety.
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MATERIALS AND METHODS
Vegetal Material and Extraction Procedure
Samples of P. reticulata Benth bark were 
collected from the Miracema city herbarium 
(Miracema, Tocantins, Brazil) in October 
2006. The specimens were deposited (protocols 
NRHTO 3327) at the herbarium of the Federal 
University of Tocantins. The bark was dried at 
40°C in an incubator with forced air circulation 
apparatus for 48 hours. The material was ground 
in a mill (MA 340®, Marconi, Brazil), macerated 
for seven days (1276.32 g) in 70% ethanol 
(14.5 liters) and the suspension was protected 
from light and percolated at 20 drops/minute, 
resulting in a 20% (w/v) hydroalcoholic extract. 
The obtained extract was then concentrated in 
a rotary evaporator (TE-210®, Tecnal, Brazil) 
and lyophilized (Multi-Tasking Freeze Drying 
S, SNL216V-115, Thermo Fisher Scientific, 
USA).
Salmonella Mutagenicity Assay
Mutagenicity was evaluated by the Salmonella 
mutagenicity assay via the Salmonella 
typhimurium strains TA97a, TA98, TA100, 
and TA102 (kindly provided by Dr. B. Ames, 
University of California, Berkeley, CA, USA), 
pre-incubated for 20 to 30 minutes with the test 
substance, with (+) or without (−) metabolic 
activation (S9) (9). The S9 mix was freshly 
prepared before each test using a lyophilized 
Aroclor-1254-induced rat liver fraction (Moltox, 
Molecular Toxicology Inc, USA). The selected 
concentrations of the extracts to be used were 
dissolved in dimethylsulfoxide (DMSO – Sigma-
Aldrich, USA). These concentrations were 
chosen based on the bacterial toxicity assay in 
a preliminary test. In all subsequent assays, the 
upper limit of the dose range tested was either the 
highest non-toxic dose or the lowest toxic dose 
determined in the preliminary assay (2.84, 5.68, 
11.37, and 19.90 mg/plate).
Toxicity was apparent either as a reduction in 
the number of His+ revertants or as an alteration 
in the auxotrophic background lawn. The various 
concentrations of samples were added to 500 µL of 
buffer (pH 7.4) or 500 µL of S9 mixture (4%) and 
100 µL of bacterial culture and then incubated at 
37°C for 20 to 30 minutes. After this time, 2 mL 
of top agar was added to the mixture and poured 
onto a plate containing minimal agar. The plates 
were incubated at 37°C for 48 hours and the His+ 
revertant colonies were manually counted.
All experiments were performed in triplicate. 
The standard mutagens used as positive 
controls in -S9 experiments were 4-nitro-o-
phenylenediamine (10 µg/plate) for TA98 and 
TA97a, sodium azide (1.25 µg/plate) for TA100 
and mitomycin (0.5 µg/plate) for TA102. In +S9 
tests, 2-anthramine (0.125 µg/plate) was used for 
all strains. DMSO served as the negative (solvent) 
control.
The statistical analysis was performed with 
the Salanal computer program, adopting the 
Bernstein et al. model (10). The data (revertants/
plate) were assessed by analysis of variance 
(ANOVA), followed by linear regression. The 
mutagenic index (MI), defined as the average 
number of revertants per plate divided by the 
average number of revertants per plate in the 
negative (solvent) control, was calculated for each 
dose. A sample was considered positive when MI 
was greater than or equal to 2 for at least one of 
the tested doses and if it had a reproducible dose-
response curve (11).
Cell Line and Culture Conditions 
Chinese hamster ovary cells (CHO-K1 lineage, 
ATCC number CCL-61) were maintained at 37°C 
in 5% CO2 and 97% humidity in RPMI 1640 tissue 
culture medium (Gibco, USA), supplemented 
with 10% (v/v) fetal bovine serum (FBS – Gibco), 
1% (v/v) L-glutamine (L-Glu – Gibco), 1% 
(v/v) penicillin-streptomycin (PS – Gibco) and 
0.1% (v/v) amphotericin B (Gibco) (12). For 
subculturing and experiments, the cells were 
harvested using 0.05% (w/v) trypsin and 0.02% 
(w/v) ethylene diamine tetracetic acid (EDTA) 
in a saline phosphate-buffered solution, pH 7.4. 
Each trypsinization was recorded as one passage. 
The test was performed at the third passage.
In Vitro Micronucleus Test
This experiment was carried out according 
to the procedure OECD 487 from the Guideline 
for the Testing of Chemicals (13). The test was 
performed in six-well plates in the presence (+) or 
absence (-) of the S9 metabolic activation system, 
and the cultures were in duplicate. The procedure 
was carried out in steps, as follows:
1. Time and conditions of cell culture
CHO-K1 cells were seeded at a concentration 
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of 3 x 104 cells per well and incubated for 24 hours 
at 37°C in a humidified 5% CO2 atmosphere. 
2. Removal of the medium to addition of 
treatments
The culture media were removed from the 
plates and the cells were treated either with the 
control or the hydroalcoholic extract at 0.5, 1.6 or 
5 µg/mL concentrations, which were defined after 
the cytotoxicity evaluations (data not shown). The 
-S9 assay was carried out on plates containing the 
extract at three different concentrations, using 0.5 
μg/mL mitomycin C and 0.08 μg/mL colchicine 
as a positive control. To carry out the +S9 
assay, approximately 75 μL of the S9 metabolic 
activation mixture was added to the plates that 
already contained 5 μg/mL cyclophosphamide 
and 3 μg/mL benzopyrene as positive controls 
and the extract at the different concentrations as 
previously described.
3. Incubation for four hours
4. Addition of cytochalasin B with medium
•	 On the –S9 plates, cytochalasin B solution 
was added to the wells at 3 μg/mL final 
concentration.
•	 On the +S9 plates, first the media were 
removed by aspiration, and the cells were 
rinsed with a phosphate buffer solution (pH 
7.4) and replenished with complete medium 
containing 3 μg/mL cytochalasin B.
5. Twenty more hours of culturing
Both treatments (-S9 and +S9) returned to the 
incubator for an additional 20-hour incubation 
period. Afterward, the cultures were processed 
using subculture procedures to prepare slides for 
analysis (as described below).
6. Preparation and analysis of slides
The cell suspension was washed with 5 mL 
of 0.9% (w/v) saline solution, and after five 
minutes the cells were fixed by adding 5 mL of 
methanol/acetic acid (3:1 v/v) for five minutes. 
After fixation, the cell suspension was centrifuged 
at 1,500 rpm for five minutes. The re-suspended 
cells were dropped on wet-clean glass slides 
inside a thermostated bath, set at 65°C, for three 
minutes and left to air dry.
The slides were stained for 15 minutes with 
Giemsa (Gibco) 5% in Sörensen buffer, rinsed 
with distilled water, coded and analyzed with an 
optical microscope (Nikon, Model Alphaphot-2 
YS2-H, USA), at 400x magnification. The 
mononucleate, binucleate and multinucleate 
cells were counted by using the cytokinesis-
block proliferation index (CBPI) and replicative 
index (RI) in agreement with the equations for 
cytotoxicity assessment, which are described in 
the OECD 487 guideline (13).
For statistical analysis, the binomial proportion 
confidence interval (Poisson model) was adopted 
and the variation was assessed by using a one-way 
analysis of variance (ANOVA) between negative 
controls (samples with and without S9 mix) and 
positive controls (+ and –S9 mix) (14). 
RESULTS AND DISCUSSION
Brazil has a very large number of native plant 
species that are considered medicinal (15-17). 
However, many of them have not yet been studied 
for medicinal purposes. P. reticulata Benth, a 
tree that grows in dry areas of central Brazil, has 
potential medicinal, forestry, ink and ornamental 
applications (18). Caramori et al. (19) analyzed 
and quantified the presence of compounds such 
as lectins and trypsin-like inhibitors, polyphenols 
and tannins, and the enzymatic activity of 
peroxidases and proteases from the seeds of P. 
reticulata.
The safe use of plants is commonly assumed in 
traditional medicine. This safety is based on their 
long usage in the treatment of diseases according 
to knowledge accumulated over centuries. 
However, recent scientific data have shown 
that many plants used as food or in traditional 
medicine are potentially toxic, mutagenic or 
carcinogenic (20). In addition, epidemiological 
data support the idea that tannins, among other 
vegetal antioxidant agents, have the ability to 
modulate certain cell signaling pathways and gene 
expression (21, 22). The present study observed 
the mutagenic potential of P. reticulata bark in 
order to ensure its safety for human use.
Of the approximately 1276.32 g of P. reticulata 
Benth dried bark processed, 1256.37 g of the 
powdered drug was obtained, resulting in 98.43% 
(w/w) purity. After percolation of the powdered 
drug, the 16 liters of hydroalcoholic extract 
obtained was concentrated down to 780 mL and 
lyophilized, thus producing 327.73 g that was 
properly stored until usage.
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Table 1 shows the mutagenic activity of 
hydroalcoholic extract from P. reticulata bark 
using S. typhimurium strains. These strains have 
a defect in one of the genes involved in histidine 
biosynthesis. The defect renders the cell dependent 
(auxotrophic) on exogenous histidine. Unless the 
cell experiences a mutation that causes reversion 
of the dysfunctional gene back to the wild type 
(prototrophic), the cell becomes disabled when 
the exogenous histidine is exhausted. For this 
reason, this assay is referred to as a reverse or 
back mutation assay. Since a single strain of a 
bacterium is capable of detecting only a specific 
type of genetic damage, several strains must be 
used to effectively screen for mutagenic potential. 
The S. typhimurium strains detect reversion from 
His- to His+ at a single site in one of the 12 steps of 
histidine biosynthesis. Strains TA97 (hisD6610) 
and TA98 (hisD3052) are reverted from histidine 
auxotrophy to histidine prototrophy by frameshift 
mutagens, whereas TA100 (hisG46) is reverted by 
base substitution mutagens. 
Strain TA102 (hisG428) possesses A-T base 
pairs at the site of the mutation unlike other S. 
typhimurium tester strains that possess G-C 
base pairs at the mutation sites. In addition, 
TA102 has been shown to be useful for detecting 
oxidative mutagens that are not detected by 
other tester strains (23). The hydroalcoholic 
extract was mutagenic to the TA98 strain (–S9), 
which can be clinically relevant since one of its 
popular uses is in cases of diarrhea or dysenteries 
(2). Thus, its oral administration can lead to an 
increase of gastrointestinal cancer, although its 
biotransformation determines the mutagenic 
activity loss, as shown using metabolic activation 
(+S9). 
The P. reticulata extract also showed signs (a 
significant increase in revertants, but MI < 2) of 
mutagenicity to TA97a and TA102 (both –S9). 
To increase the sensitivity to mutagens, several 
additional mutations have been incorporated into 
the strains used in the standard assay, including 
in the uvrB gene of S. typhimurium. Cells with 
this type of mutation are unable to repair damage 
Table 1. Ames test (Salmonella typhimurium) for mutagenic activity (mean number of revertants/plate ± 
SD) of the bacterial strains TA97a, TA98, TA100 and TA102 exposed to Plathymenia reticulata hydroalcoholic 
extract, at various concentrations, with (+) and without (-) metabolic activation (S9)
Salmonella typhimurium strains
TA97a TA98 TA100 TA102
Treatment 
mg/plate -S9a +S9b -S9a +S9b - S9c +S9b - S9c +S9d
0 122 ± 21.5 133 ± 2.0 22 ± 4.0 25 ± 3.6 127 ± 1.5 147 ± 9.5 190 ± 18.9 272 ± 21.5
2.84
171 ± 25.2
(1.4)
127 ± 8.9
(1.0)
19 ± 1.5
(0.8)
19 ± 0.6
(0.7)
172 ± 30.1
(1.3)
118 ± 6.2
(0.8)
255 ± 8.1**
(1.5)
257 ± 9.2
(0.9)
5.68
183 ± 10.0*
(1.5)
137 ± 5.9
(1.0)
31 ± 6.1
(1.4)
24 ± 0.6
(0.9)
134 ± 19.0
(1.0)
118 ± 8.0
(0.8)
289 ± 25.5**
(1.8)
243 ± 21.4
(0.8)
11.37
203 ± 15.3*
(1.7)
138 ± 9.6
(1.0)
31 ± 11.1
(1.4)
20 ± 6.4
(0.8)
153 ± 23.7
(1.2)
126 ± 9.2
(0.9)
220 ± 20.6
(1.2)
226 ± 11.3
(0.8)
17.06
210 ± 15.9*
(1.7)
146 ± 8.0
(1.1)
44 ± 11.2*
(2.0)
25 ± 6.0
(1.0)
171 ± 17.2
(1.3)
128 ± 5.7
(0.9)
208 ± 9.2
(1.2)
221 ± 22.9
(0.8)
19.90
223 ± 10.7**
(1.8)
126 ± 8.0
(0.9)
54 ± 10.9*
(2.4)
22 ± 0.8
(0.8)
173 ± 77.4
(1.3)
125 ± 4.5
(0.9)
233 ± 21.1
(1.3)
192 ± 13.3
(0.7)
Control + 1251 ± 44.2 1258 ± 52.1
1885 ± 
12.5
733 ± 
127.8
1157 ± 
207.6 1243 ± 122 886 ± 122.6 854 ± 59.9
0: negative control (DMSO, 100 mL/plate); +: positive control. a NPD (4-nitro-o-phenylenediamine – 10.0 mg/plate); b 2-anthramine 
(1.25 mg/plate); c sodium azide (1.25 mg/plate); d mitomycin (0.5 mg/plate). 
The values in parenthesis represent the mutagenic index [MI, red color, * p < 0.05 (ANOVA)] or signs of mutagenicty [green color, 
** p < 0.05 (ANOVA)].
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induced by UV light or other types of mutagens. 
The uvrB mutation has not been introduced in 
TA102 (23). Although the mutagenic index of P. 
reticulate extract for TA102 was not expressive, the 
result shows sensitivity to oxidative compounds 
present in the extract and to UV light. The results 
obtained using TA100 showed no mutagenic 
activity of P. reticulata extract, signifying a certain 
inability to cause base substitution (either in –S9, 
as in +S9).
The micronucleus test in CHO-K1 cells is 
able to detect chromosome fragments or lagging 
intact chromosomes in the cytoplasm of cells that 
have undergone division (24). The study of DNA 
damage at the chromosome level is an essential 
part of genetic toxicology because chromosomal 
mutation is an important event in carcinogenesis. 
The micronucleus assay has emerged as a new 
method for assessing and for routine screening 
of agents that damage chromosomes (25, 26). The 
micronucleus counts were obtained for all cells 
(mononucleate, binucleate, multinucleate cells), 
but only the binucleate cells were used in the 
Poisson model (14). 
Figure 1 indicates that the RI percentages 
were higher than 77% for the –S9 samples and 
were above 90% for the +S9 samples. The RI 
percentages for the –S9 samples corresponded 
to 94.1% at 0.5 μg/mL, 96.9% at 1.6 μg/mL and 
97.7% at 5 μg/mL of the extract. The positive 
control percentages were 85.2% for mitomycin 
C and 77.5% for colchicine. The RI percentages 
obtained for the +S9 samples were 91.2% at 0.5 
μg/mL, 92.5% at 1.6 μg/mL and 91.4% at 5 μg/mL 
of the extract.
The percentages calculated for benzopirene 
and cyclophosphamide were 93.4% and 100.8%, 
respectively. According to the OECD-487 
procedure (13), the highest concentration should 
result in around 50 ± 5% cytotoxicity. Higher levels 
may induce chromosome damage as a secondary 
effect of cytotoxicity. The highest cytotoxicity 
percentage was 22.5% and corresponded to 
colchicine (Figure 1). Based on this information, 
the performed experiments provided reliable 
results. The concentrations of test substance and 
positive controls were adequate for the samples 
and were chosen using specific guidelines.
The CBPI indicates the average number of cell 
divisions per cell during the period of exposure 
to cytochalasin B and may be used to estimate 
cell proliferation (13). This method is based on 
the frequent induction of cell cycle arrest, which 
is reflected by a decreased ratio of binucleate to 
mononucleate cells when using cytochalasin 
B. In this method, the level 1 (all cells are 
Figure 1. Micronucleus test (CHO-K1 line) and replication Index (RI, mean expressed as percentage). Cells 
were treated with the extract in the presence (+) and absence (-) of metabolic activation (S9). The (–) control 
corresponds to the culture medium; (+) control 1 corresponds to benzo(a)pyrene (in experiments with S9) 
and mitomycin C (in experiments without S9); (+) control 2 is related to colchicine in the absence of S9 and 
to cyclophosphamide in the S9 treated cells. CHO: Chinese hamster ovary.
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mononucleate) of CBPI is equivalent to 100% 
cytostasis (13, 27). Our results showed that the 
sample concentrations were not cytotoxic.
According to theoretical considerations and 
published data, most aneugens and clastogens are 
detectable during a short treatment period of 3 
to 6 hours in the presence (+) or absence (–) of 
S9, followed by removal of the tested substance 
and a recovery period of 1.5 to 2.0 cell cycles (28, 
29). In the +S9 assay, the cultures were incubated 
during a four-hour exposure period. After the 
treatment period, the cultures were returned to 
the incubator for an additional 20 hours. This 
time corresponds to approximately 1.5 cell cycles, 
since CHO-K1 cells have an average doubling 
time of approximately 14 hours.
Exogenous metabolizing systems are required 
when cells with inadequate endogenous metabolic 
capacity are involved in in vitro experiments. 
The most common system used is a cofactor-
supplemented post-mitochondrial fraction 
prepared from the livers of rodents that were 
treated with enzyme-inducing agents (13). For 
the in vitro micronucleus test, Aroclor-induced 
rat liver S9 homogenate was adopted as an 
exogenous activation system. According to Figure 
2, the exogenous metabolism system increased 
the number of viable cells when compared to the 
–S9 samples (p < 0.05). 
The mutagenic effect of P. reticulata was 
evaluated by the micronucleus test. According to 
Table 2, this percentage was lower than the +S9 
negative control. For the +S9 and -S9 positive 
controls, the percentages were higher than the 
other samples. However, this was not observed for 
colchicine, which presented a lower micronucleus 
percentage than the test concentrations of P. 
reticulata extract.
The micronucleus frequency corresponds to 
the compound’s mutagenic capacity and is based 
on the total count of micronuclei divided by the 
total number of binucleate cells. It was noted that 
the P. reticulata extract was less mutagenic when 
applied to +S9 cells, a fact supported by a lower 
micronucleus frequency. As expected, there was a 
positive proportional increase in the micronucleus 
percentage between the -S9 and +S9 sample 
concentrations. It was also shown that colchicine 
did not provide an adequate positive control 
due to its low aneugenic potential, as observed 
through the low micronucleus occurrence. 
Reifferscheid et al. (30) confirmed that the 
optional positive control colchicine induced 
micronuclei only in a very narrow concentration 
Figure 2. Micronucleus test (CHO-K1 line) and cytokinesis-block proliferation index (CBPI, average number 
of cell divisions per cell of the slides of the two wells ±SD). Values obtained from the samples in the presence 
(+) and absence (-) of metabolic activation (S9). The (-) control corresponds to the culture medium of 
each sample; (+) control 1 employed mitomycin C and benzopyrene in - and + S9 samples for metabolic 
activation, respectively; (+) control 2 is related to colchicine in the -S9 samples and to cyclophosphamide 
for the +S9 samples. CHO: Chinese hamster ovary.
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range between 0.01 and 0.015 μg/mL. Higher 
concentrations of the aneugenic substance led to 
polyploid cells and, eventually, to cell death. Both 
conditions are unfavorable for the test evaluation, 
which is one reason for not considering this 
substance a standard positive control in the ISO 
draft.
The micronucleus frequency was about 2.9 
higher for the -S9 samples in relation to the 
negative control, even though the retained 
percentage was lower than the positive controls. 
P. reticulata Benth hydroalcoholic extract did 
not present a mutagenic effect potential at 
concentrations of 0.5, 1.6 and 5 μg/mL, mainly 
when the test was performed with the S9 
metabolic activation system by both the Ames 
and micronucleus tests.
Results that express mutagenic activity 
may suggest that a specific agent is not safe for 
medicinal use. The positive mutagenicity property 
may exclude a plant from any further trial of 
preclinical tests, a crucial step in the development 
of new agents with clinical relevance (31, 32). 
Therefore, careful observation of cause and effect, 
followed by a coordinated approach to identify 
the responsible entities, would be extremely 
fruitful in discovering new therapeutic roles for 
the phytochemical constituents of P. reticulata, 
for example, as antitumoral agents.
P. reticulata extract – in spite of its previously 
demonstrated anti-inflammatory, antimicrobial 
and antiophidian effects– can also alter 
genetic properties, as shown by the Salmonella 
microsome and micronucleus tests, both of 
which are –S9 (3, 4, 8). The antiophidian ability 
of P. reticulata extract was attributed to the 
presence of tannins, which act by precipitating 
venom proteins, also reproduced by commercial 
tannic acid. Both tannins and tannic acid 
significantly inhibit not only the impairment of 
muscle strength induced by Crotalus durissus 
terrificus and Bothrops jararacussu venoms, but 
also the lethality of cobra (Naja kaouthia) venom 
(8, 33). This protein-precipitating property of P. 
reticulata extract could limit its clinical use as 
a topical application - mainly against the local 
manifestation in cases of Bothrops snakebites 
due to high myotoxic action, but strategies 
for producing a hemoperfuser containing 
tannic acid and/or plant tannins as adsorbent 
could be considered for treating severe snake 
envenomation. Likewise, taken together, these 
results also indicate a probable new antitumoral 
property, which must be investigated in 
additional studies using isolated bioactive 
compounds, given that it is easier to ensure 
safety in the action of a single molecule rather 
than a mixture of compounds.
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* p < 0.05 (ANOVA); CHO: Chinese hamster ovary.
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